open access

Vol 76, No 5 (2008)
ORIGINAL PAPERS
Published online: 2008-09-17
Submitted: 2013-02-22
Get Citation

Allergic rhinitis - an epidemiological, economical and social problem of the XXI century

Ryszard Rutkowski, Bożena Kosztyła-Hojna, Joanna Rutkowska
Pneumonol Alergol Pol 2008;76(5):348-352.

open access

Vol 76, No 5 (2008)
ORIGINAL PAPERS
Published online: 2008-09-17
Submitted: 2013-02-22

Abstract

Exposure of nasal mucosa to various allergic and/or non-allergic stimuli might result in rhinitis. Allergic rhinitis affects 10-25% of population making it the most prevalent allergic disorder. Seasonal and perennial allergic rhinitis affect up to 30% and 10% of pediatric population, respectively. Prevalence of allergic rhinitis varies between studies: in Poland, Breborowicz et al. reported allergic rhinitis in 16.7% of children aged 6-7, whereas Emeryk et al. observed perennial allergic rhinitis in 3.6% and seasonal allergic rhinitis in 6.2% of 8-15 year olds.
Allergic rhinitis similarly to other diseases results in direct, indirect and hidden costs. In the USA (2002) direct costs were estimated at $4.195 billions and indirect at $665 millions (total of $4.863 billions).
Allergic rhinitis co-exists with multiple respiratory conditions, significantly increasing treatment costs incurred by patients’ and places additional burden on public finances. It also has a detrimental effect on patients’ and their families’ quality of life.
Allergic rhinitis - although non-life threatening - significantly worsens quality of daily life and as such should be perceived as a serious medical condition not only by patients but also by medical professionals who are in position to diagnose it and implement appropriate therapeutic interventions.

Abstract

Exposure of nasal mucosa to various allergic and/or non-allergic stimuli might result in rhinitis. Allergic rhinitis affects 10-25% of population making it the most prevalent allergic disorder. Seasonal and perennial allergic rhinitis affect up to 30% and 10% of pediatric population, respectively. Prevalence of allergic rhinitis varies between studies: in Poland, Breborowicz et al. reported allergic rhinitis in 16.7% of children aged 6-7, whereas Emeryk et al. observed perennial allergic rhinitis in 3.6% and seasonal allergic rhinitis in 6.2% of 8-15 year olds.
Allergic rhinitis similarly to other diseases results in direct, indirect and hidden costs. In the USA (2002) direct costs were estimated at $4.195 billions and indirect at $665 millions (total of $4.863 billions).
Allergic rhinitis co-exists with multiple respiratory conditions, significantly increasing treatment costs incurred by patients’ and places additional burden on public finances. It also has a detrimental effect on patients’ and their families’ quality of life.
Allergic rhinitis - although non-life threatening - significantly worsens quality of daily life and as such should be perceived as a serious medical condition not only by patients but also by medical professionals who are in position to diagnose it and implement appropriate therapeutic interventions.
Get Citation

Keywords

allergic rhinitis; epidemiology; economy; social problems

About this article
Title

Allergic rhinitis - an epidemiological, economical and social problem of the XXI century

Journal

Advances in Respiratory Medicine

Issue

Vol 76, No 5 (2008)

Pages

348-352

Published online

2008-09-17

Bibliographic record

Pneumonol Alergol Pol 2008;76(5):348-352.

Keywords

allergic rhinitis
epidemiology
economy
social problems

Authors

Ryszard Rutkowski
Bożena Kosztyła-Hojna
Joanna Rutkowska

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl